Company page

Glaukos Corporation

Glaukos Corporation, trading under the ticker GKOS, is a public company based in America with a market capitalization of approximately $7.68 billion. The company focuses on developing innovative therapies for the treatment of glaucoma and other eye diseases. Glaukos aims to improve patient outcomes through advanced surgical and pharmaceutical solutions.